Production & Manufacturing

Mylan Laboratories has agreed to purchase SMS Pharmaceuticals' manufacturing unit-VI in Visakhapatnam, Andhra Pradesh, India, for a total sum of INR1.73bn ($33m). The manufacturing unit was designed for the production of cancer medications and...

Biostar Pharmaceuticals has entered into an agreement worth $3m to manufacture and supply five additional drugs to Xijing Hospital for one-year. The five drugs include Qing Wen Granule, Ru Xiao Kang Capsule, Stomach and...

Pfizer and Mylan have entered into a collaboration agreement to develop, manufacture, distribute and market generic drugs in Japan. Under the agreement, Pfizer will take responsibilities for the commercialization of the combined generics portfolio,...

Alexza Pharmaceuticals, a pharmaceutical company, has received EU Certificate of GMP Compliance for its Adasuve manufacturing facility. In May 2012, Alexza hosted an EU GMP inspection, which was conducted by the Agencia Espanola de...

Tris Pharma has initiated an expansion of its manufacturing capacity earlier in 2012 and is roughly midway through a 15 month expansion. The expansion will take the company's footprint from its current 90,000ft² to...

Specialty pharmaceutical company, Merus Labs International, has acquired Emselex/Enablex (darifenacin) extended release tablets rights from Novartis Pharma in Canada and Europe, excluding France, Spain and Italy. As part of the acquisition, Merus Labs will...

Xcellerex, a provider of manufacturing technologies, has launched new XDR-10 single-use bioreactor. The new system, which is available in single-, twin-, triplet-, and quad-vessel configurations, is flexible to handle volumes from 4l to 10l....